Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025

Abstract Objective Rare diseases are life-threatening, debilitating, or serious chronic conditions that affect < 50/100,000 people. Canadians can only access approximately 60% of drugs for rare diseases (DRDs), which is partially related to high per-patient costs and payers’ affordability concern...

Full description

Bibliographic Details

Published in:	Orphanet Journal of Rare Diseases
Main Authors:	Richard Lech, Gideon Chow, Kamalpreet Mann, Patrick Mott, Christine Malmberg, Lindy Forte
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Subjects:	Canada Drugs for rare diseases Orphan drugs Drug funding Orphan diseases Patient access
Online Access:	https://doi.org/10.1186/s13023-022-02534-z